低温EM证据表明阿尔茨海默氏症和其他神经退行症的常见因素
1Neuropathology, Cellular Pathology, South West London Pathology, St George's Hospital, St George's University Hospitals NHS Foundation Trust, London, UK and Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
bioRxiv : the preprint server for biology
|June 4, 2025
概括
一个共同的分子因素,可能是RNA,可能会将阿尔茨海默氏症和其他神经退行性疾病联系起来. 在冷电磁图中观察到的这一发现表明了潜在的统一基础和新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 结构生物学 结构生物学
背景情况:
- 电子显微镜 (cryo-EM) 在各种神经退行性疾病中揭示了神经病理纤维.
- 在这些纤维素中一直观察到与氨酸残留物协调的未识别的成分.
- 之前的分析在描述这个未知的组成部分时遇到了挑战.
研究的目的:
- 用先进的可视化软件重新评估和描述神经病理纤维的未知成分.
- 在不同的神经退行性疾病中识别该组件的共同特征和潜在分子身份.
- 探索一个共同的分子因子对理解神经退行症和开发治疗方法的影响.
主要方法:
- 对神经病理纤维素 (阿尔茨海默氏症,病,同核病等) 的公开可用的冷EM地图进行分析. ) 的情况.
- 使用UCSF ChimeraX可视化软件进行详细的结构检查.
- 与氨酸残留物和其他环境相关的额外密度的比较分析.
主要成果:
- 在各种神经退行性纤维的氨酸协调密度中,发现了包括Y形子结构在内的共同特征.
- 这种常见的成分被观察到在纤维细胞中,包括β-粉样蛋白,α-synuclein,蛋白,tau和跨膜蛋白106B.
- 与TAR DNA结合蛋白43和TATA结合蛋白相关因子15相关的纤维素中发现了类似的密度.
- 结果表明这些疾病中常见的主要是阴离子聚合物分子因子.
结论:
- 一个共同的分子因素,可能是RNA,将各种神经退行性疾病联系在一起,包括阿尔茨海默氏症.
- 这表明这些条件可能有一个统一的基础.
- 这些发现为针对这种共同因素的新型诊断测试和治疗策略开辟了可能性.
相关概念视频
01:26Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
01:28Cryo-electron Microscopy
3.3K
Conventional electron microscopy (EM) involves dehydration, fixation, and staining of biological samples, which distorts the native state of biological molecules and results in several artifacts. Also, the high-energy electron beam damages the sample and makes it difficult to obtain high-resolution images. These issues can be addressed using cryo-EM, which uses frozen samples and gentler electron beams. The technique was developed by Jacques Dubochet, Joachim Frank, and Richard Henderson, for...
3.3K
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
03:03Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K